MedPath

翔宇药业股份有限公司

Ownership
-
Established
2000-10-23
Employees
-
Market Cap
-
Website
http://www.xiangyuyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

44

NMPA:44

Drug Approvals

Sodium Valproate Oral Solution

Product Name
丙戊酸钠口服溶液
Approval Number
国药准字H20243495
Approval Date
Jul 30, 2024
NMPA

妇科止血灵胶囊

Approval Number
国药准字Z20090633
Approval Date
Oct 24, 2023
NMPA

产后逐瘀颗粒

Approval Number
国药准字Z20090589
Approval Date
Oct 24, 2023
NMPA

全天麻片

Approval Number
国药准字Z20090874
Approval Date
Oct 24, 2023
NMPA

丹参片

Approval Number
国药准字Z20093362
Approval Date
Oct 24, 2023
NMPA

香麻寒喘贴

Approval Number
国药准字Z20184062
Approval Date
Jun 24, 2023
NMPA

心可宁胶囊

Approval Number
国药准字Z20174056
Approval Date
Aug 26, 2022
NMPA

颐神颗粒

Approval Number
国药准字B20171005
Approval Date
Aug 26, 2022
NMPA

解郁安神颗粒

Approval Number
国药准字Z20174004
Approval Date
Feb 12, 2022
NMPA

Secnidazole Capsules

Product Name
塞克硝唑胶囊
Approval Number
国药准字H20070304
Approval Date
Dec 30, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.